Is Alkem financially strong?

Yes, it has consistent revenue growth, rising profits, good margins, EPS growth, and pays regular dividends, making it a solid long-term investment option.

How much profit does Alkem make?

Net profit increased from ₹1,149 million in March 2020 to ₹2,215 million in March 2025, and TTM net profit is ₹2,410 million.

What is the P/E ratio of Alkem?

Its P/E ratio is ~28 as of December 2025.

Stock

Dividend Stocks | Share Price Target

Alkem Laboratories Share Price Target 2025, 2026, 2030, 2040, 2050

Read More Alkem Laboratories Share Price Target 2025, 2026, 2030, 2040, 2050
Share Price Target | Dividend Stocks

Blue Jet Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050

Read More Blue Jet Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050
Share Price Target | Dividend Stocks

Zydus Lifesciences Share Price Target 2025, 2026, 2030, 2040, 2050

Read More Zydus Lifesciences Share Price Target 2025, 2026, 2030, 2040, 2050
Share Price Target

Indegene Share Price Target 2025, 2026, 2030, 2040, 2050

Read More Indegene Share Price Target 2025, 2026, 2030, 2040, 2050
IPO

KSH International ipo date, Share Price Target Tomorrow, 2025, 2026, 2030

Read More KSH International ipo date, Share Price Target Tomorrow, 2025, 2026, 2030
Share Price Target | Dividend Stocks

Abbott India Share Price Target 2025, 2026, 2030, 2040, 2050

Read More Abbott India Share Price Target 2025, 2026, 2030, 2040, 2050
Share Price Target | Dividend Stocks

Emcure Pharma Share Price Target 2025, 2026, 2030, 2040, 2050

Read More Emcure Pharma Share Price Target 2025, 2026, 2030, 2040, 2050
Dividend Stocks | IPO

ICICI Prudential AMC ipo date, Share Price Target Tomorrow, 2025, 2026, 2030

Read More ICICI Prudential AMC ipo date, Share Price Target Tomorrow, 2025, 2026, 2030
IPO

Park Medi World ipo date, Share Price Target Tomorrow, 2025, 2026, 2030

Read More Park Medi World ipo date, Share Price Target Tomorrow, 2025, 2026, 2030